Ignite Creation Date:
2024-05-06 @ 9:52 AM
Last Modification Date:
2024-10-26 @ 12:21 PM
Study NCT ID:
NCT03097601
Status:
COMPLETED
Last Update Posted:
2020-07-21
First Post:
2017-03-27
Brief Title:
ELRCXCL Cytokines in Metastatic Kidney Cancers Predictive Markers of Resistance to Sunitinib
Sponsor:
Organization:
Centre Antoine Lacassagne
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Experiment on cell lines on human samples and animal models CXCL cytokines as predictive markers of sunitinib efficacy in order to demonstrate the mechanisms linked to the production of CXCL cytokines by mRCC or in response to treatments
Enrollment Count:
60
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 40353 |
Who Masked List: